FdaApplication
ANDA 203041
Identifiers
- fda_app_no: ANDA203041
Properties
| Property | Value |
|---|---|
| applicant_name | AUROBINDO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2018-09-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 600MG;200MG;300MG | TABLET;ORAL |
1 product